Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024

Stock Price vs Company Growth
1d
3.9%
1w
8.0%
1m
20.4%
3m
38.0%
6m
62.4%
1y
92.5%
all
55.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,640 3.9%
1,172
1,658
Company Overview

Sales
2,250 Cr
Growth: 18.0%
Profit after Tax
361 Cr
Growth: 3.7%
Large Cap
34,843 Cr
P/E: 96.9x
Industry P/E: 34.2x
Fundamentals

Sales (Cr) ₹ 2,250
Growth 18.0%
EBITDA 29.3%
P/S 15.5x
Dividend 0.0%
P/E 96.9x
Book Value ₹ 120
PEG Ratio 5.2x
ROE 14.9%
P/B 13.1x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms. Awards, accreditations and recognitions2020: Awarded the ‘Risk Mitigation Award’ by Institute of Supply Chain Management Pvt. Ltd.
Followers (1)